GlassScriptPhysician profile
Brian R Shaw
NPI 1578890570
$2,126.27
in general payments reported to CMS, 2019-2025
20 companies · $27.26 in 2025
The $27.26 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $557 · 2021: $395 · 2022: $273 · 2023: $316 · 2024: $59.40 · 2025: $27.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $406.23 | 2019-2021 | |
| Abiomed | $361.69 | 2019-2025 | |
| Avinger INC. | $217.35 | 2020-2021 | |
| Boston Scientific Corporation | $198.64 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $163.71 | 2023-2024 | Optimizer, Optimizer |
| Medtronic Vascular, INC. | $126.84 | 2019 | |
| Philips North America LLC | $113.36 | 2023 | |
| Inari Medical, INC. | $110.15 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $87.85 | 2022-2024 | |
| Astellas Pharma US INC | $79.99 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $76.13 | 2019-2023 | Andexxa |
| Biotronik INC. | $34.63 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $30.40 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $25.52 | 2020-2021 | |
| Amgen INC. | $20.56 | 2024 | Repatha |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $17.83 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.58 | 2022 | |
| Lantheus Medical Imaging, INC. | $14.58 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.21 | 2019 | |
| Terumo Medical Corporation | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.